What is the first‑line medication for acute bacterial sinusitis?

First-Line Medication for Acute Bacterial Sinusitis

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5–10 days is the preferred first-line antibiotic for adults with acute bacterial sinusitis, providing 90–92% predicted clinical efficacy against the major pathogens. 1, 2

Confirming the Diagnosis Before Prescribing Antibiotics

Before initiating any antibiotic, you must confirm that the patient meets at least one of three diagnostic patterns for acute bacterial rhinosinusitis (ABRS):

• Persistent symptoms ≥10 days with purulent nasal discharge plus either nasal obstruction or facial pain/pressure/fullness 1, 3
• Severe symptoms ≥3–4 consecutive days with fever ≥39°C (102.2°F), purulent nasal discharge, and facial pain 1, 4
• "Double sickening": initial improvement from a viral upper respiratory infection followed by worsening symptoms within 10 days 1, 3

Critical context: Approximately 98–99.5% of acute rhinosinusitis cases are viral and resolve spontaneously within 7–10 days without antibiotics. 1, 5 Do not prescribe antibiotics for symptoms lasting <10 days unless the severe criteria above are met. 1, 3

First-Line Antibiotic Regimen

Standard Adult Dosing

Amoxicillin-clavulanate 875 mg/125 mg orally twice daily is the guideline-recommended first choice for otherwise healthy adults. 1, 2 The clavulanate component is essential because 30–40% of Haemophilus influenzae and 90–100% of Moraxella catarrhalis produce β-lactamase, rendering plain amoxicillin ineffective against these organisms. 1, 2

Treatment Duration

Continue therapy for 5–10 days or until the patient is symptom-free for 7 consecutive days (typically 10–14 days total). 1, 3 Recent evidence supports shorter 5–7 day courses as equally effective with fewer adverse effects compared to traditional 10-day regimens. 1

High-Dose Regimen for Risk Factors

Use high-dose amoxicillin-clavulanate 2 g/125 mg twice daily when any of the following risk factors are present: 1, 3

• Recent antibiotic use within the past 4–6 weeks
• Age >65 years
• Daycare exposure (for children)
• Moderate-to-severe symptoms
• Comorbidities (diabetes, chronic cardiac/hepatic/renal disease)
• Immunocompromised state

Alternatives for Penicillin Allergy

Non-Severe (Non-Type I) Penicillin Allergy

For patients with mild, delayed-type reactions (e.g., rash), prescribe a second- or third-generation cephalosporin for 10 days: 1, 2

• Cefuroxime-axetil
• Cefpodoxime-proxetil
• Cefdinir
• Cefprozil

Cross-reactivity with penicillins is negligible (<1%) for these agents. 1

Severe (Type I/Anaphylactic) Penicillin Allergy

For patients with documented anaphylaxis, urticaria, or angioedema to penicillins, use a respiratory fluoroquinolone: 1, 3

• Levofloxacin 500 mg once daily for 10–14 days, OR
• Moxifloxacin 400 mg once daily for 10 days

Both achieve 90–92% predicted efficacy against multidrug-resistant Streptococcus pneumoniae and β-lactamase-producing organisms. 1

Suboptimal Alternative

Doxycycline 100 mg once daily for 10 days is acceptable only when cephalosporins and fluoroquinolones are contraindicated (e.g., pregnancy, tendon disorders). It provides lower efficacy (77–81%) with a 20–25% bacteriologic failure rate due to limited activity against H. influenzae. 1 Doxycycline is contraindicated in children <8 years due to tooth enamel discoloration risk. 1

Watchful Waiting as an Alternative Strategy

For adults with uncomplicated ABRS and reliable follow-up, initial observation without antibiotics is an appropriate strategy. 1, 5 Initiate antibiotics only if there is no improvement by day 7 or if symptoms worsen at any time. 1 The number needed to treat (NNT) with antibiotics is 10–15 to achieve one additional cure compared to placebo, reflecting the high spontaneous recovery rate. 1

Essential Adjunctive Therapies (Add to All Patients)

Intranasal Corticosteroids (Strong Evidence)

Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily significantly reduce mucosal inflammation and accelerate symptom resolution. This recommendation is supported by strong evidence from multiple randomized controlled trials. 1, 3 These should be prescribed to every patient regardless of whether antibiotics are used.

Saline Nasal Irrigation

Saline nasal irrigation 2–3 times daily provides symptomatic relief and aids mucus clearance. 1, 4

Analgesics

Acetaminophen or ibuprofen for pain and fever control. 1, 4

Monitoring and Reassessment Protocol

Early Reassessment (Days 3–5)

Reevaluate the patient at 3–5 days after starting antibiotics. 1, 3 If there is no clinical improvement (persistent purulent drainage, unchanged facial pain, or worsening), switch immediately to: 1

• High-dose amoxicillin-clavulanate 2 g/125 mg twice daily, OR
• A respiratory fluoroquinolone (levofloxacin or moxifloxacin)

Later Reassessment (Day 7)

If symptoms persist or worsen at day 7, reconfirm the diagnosis, exclude complications (orbital cellulitis, meningitis, intracranial abscess), and consider imaging or ENT referral. 1, 3

Antibiotics to Avoid as First-Line Therapy

Macrolides (Azithromycin, Clarithromycin)

Never use macrolides for acute bacterial sinusitis. Resistance rates are 20–25% for both S. pneumoniae and H. influenzae. 1, 2 The American Academy of Pediatrics explicitly contraindicates azithromycin for acute bacterial sinusitis due to these resistance patterns. 1

Trimethoprim-Sulfamethoxazole

Avoid due to ≈50% resistance in S. pneumoniae and ≈27% in H. influenzae. 1

First-Generation Cephalosporins (Cephalexin)

Inadequate coverage because ≈50% of H. influenzae strains produce β-lactamase. 1

Pediatric Considerations

Standard Pediatric Dosing

For children ≥2 years without risk factors, use amoxicillin 45 mg/kg/day divided twice daily for a minimum of 10–14 days. 2, 6

High-Dose Pediatric Regimen

For high-risk children (age <2 years, daycare attendance, recent antibiotic use, or high local resistance), use high-dose amoxicillin-clavulanate 80–90 mg/kg/day (amoxicillin component) with 6.4 mg/kg/day clavulanate divided twice daily. 2, 6

Critical 72-Hour Reassessment in Children

Reassess pediatric patients at 72 hours. 6 If symptoms are worsening or failing to improve, switch immediately to high-dose amoxicillin-clavulanate. 6 This early reassessment is critical to catch treatment failures before complications develop.

Red-Flag Situations Requiring Urgent ENT Referral

Refer immediately if any of the following occur: 1, 3

• No improvement after 7 days of appropriate second-line antibiotic therapy
• Worsening symptoms at any time (increasing facial pain, fever, purulent drainage)
• Signs of complications: severe headache, visual changes, periorbital swelling/erythema, proptosis, diplopia, altered mental status, or cranial nerve deficits
• Recurrent sinusitis (≥3 episodes per year) requiring evaluation for underlying allergic rhinitis, immunodeficiency, or anatomic abnormalities

Common Pitfalls to Avoid

• Do not prescribe antibiotics for symptoms <10 days unless severe features (fever ≥39°C with purulent discharge for ≥3 consecutive days) are present 1, 4
• Do not obtain routine imaging (X-ray or CT) for uncomplicated ABRS; up to 87% of viral upper respiratory infections show sinus abnormalities on imaging, leading to unnecessary interventions 1
• Ensure adequate treatment duration (≥5 days for adults, ≥10 days for children) to prevent relapse 1, 6
• Reserve fluoroquinolones for severe penicillin allergy or treatment failure; avoid routine first-line use to prevent resistance development 1
• Be aware that gastrointestinal adverse effects with amoxicillin-clavulanate are common: diarrhea occurs in 40–43% of patients, with severe diarrhea in 7–8% 1